A multi-center international hospital-based case-control study of lymphoma in Asia (AsiaLymph) (NCI)
Revision of a currently approved collection
No
Regular
Approved with change
03/04/2016
10/30/2015
table that charts list comparision
Inventory as of this Action
Requested
Previously Approved
03/31/2019
36 Months From Approved
03/31/2016
7,423
0
8,606
3,262
0
5,302
0
0
0
This is a request for an extension of the "AsiaLymph Study" which includes non-substantive changes to the questionnaire but no changes to burden requested, scope or methodology of the study. The project focuses on collecting critically needed information to understand and reduce the cancer burden from lymphoid malignancies in the Asian population, the incidence of which has risen in recent decades. Specifically, environmental exposures to industrial emissions, genetic susceptibility, viral exposures, early life exposures, ultraviolet (UV) radiation exposures, and other risk factors for lymphoma overall and specifically for populations in Asia will continue to be examined.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.